Logo Lanfrica

Hepatitis B therapy as HIV prevention in Africa: a case series from Zambia.

Créateur:
VinSinChiKan
Éditeur:
Uni
Hôte:avatar

Similaires

HIV, syphilis and hepatitis B coinfections in Mkushi, Zambia: a cross-sectional study

Background: Human immunodeficiency virus, syphilis and hepatitis B virus (HBV)

Antiretroviral Therapy as Prevention in South Africa

Modeling shows that South Africa’s new HIV treatment guidelines could prevent almost 20% of new HIV

Screening, characterisation and prevention of Hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa

Background
In South Africa, the first HBV vaccine dose is administered at age 6 weeks, leaving

Occult hepatitis B virus infection in a Kenyan cohort of HIV infected anti-retroviral therapy naïve adults

Background Occult hepatitis B virus (HBV) infection (OBI) is a phase of HBV infection characterise

High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana

Abstract Background Hepatitis B surface antigen (HBsAg)–negative but hepatitis B virus (HBV) DNA-

Hepatitis B, Hepatitis C and HIV Prevalence and Related Sexual and Substance Use Risk Practices Among Key Populations Who Access HIV Prevention, Treatment and Related Services in South Africa: Findings from A Seven-City Cross-Sectional Survey (2017)

Abstract Background: People who use drugs including people who inject drugs (PWUD/ID), s